Wall Street hits record highs as payrolls surge. Explore healthcare stock movers, obesity drug breakthroughs, AbbVie deals, Centene struggles & ...

The stock's fall snapped a four-day winning streak.

Eli Lilly (NYSE:LLY), a major pharmaceutical company listed on the S&P 500 and NYSE Composite, continues to attract attention with developments across its legal, research, and expansion efforts. As ...

Baron Funds, an investment management company, released its “Baron Fifth Avenue Growth Fund” first quarter 2025 investor ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Over the past month, Eli Lilly's stock rose by nearly 10%, a performance that aligns with the broader upward trend of the S&P 500 and Nasdaq, which have been bolstered by easing trade tensions and ...

Wall Street’s major market averages seesawed back and forth on Friday and finished mixed as Federal Reserve Governor Christopher Waller hinted at potential rate cuts in July. The S&P 500 Health Care ...

At first glance, pharmaceutical giant Eli Lilly (LLY) may seem like an awfully risky wager. On Friday, LLY stock fell 2.47%, ...

Since I last wrote about the weight loss giant Eli Lilly and Company (NYSE:LLY) in April, its price has corrected slightly. This is in stark contrast with the S&P 500 (SP500), which is up by ...

ET, the Dow Jones Industrial Average rose 0.09%, the S&P 500 gained 0.28%, and the Nasdaq Composite added 0.40% ...

Over the past month, shares of this drugmaker have returned +4.8%, compared to the Zacks S&P 500 composite's +7.2% change. During this period, the Zacks Large Cap Pharmaceuticals industry, which ...

The S&P 500 pulled back from all‑time highs as oil jumped above $70, marking its largest weekly gain in years.